AKT1 and breast cancer: The results of the present study thus expanded our knowledge of the PI3K/Akt-SKP2-Cip/Kips pathway and highlighted the critical implication of this pathway in overcoming the drug (curcumin) resistance that is commonly observed in different subtypes of breast cancer.